Stay updated with breaking news from Yield10 Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zacks Investment Research cut shares of Yield10 Bioscience (NASDAQ:YTEN – Get Rating) from a hold rating to a sell rating in a research note published on Tuesday morning, Zacks.com reports. According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to […]
-Establishing the Camelina crop as a replenishable reserve of feedstock oil for biofuels -Winter Camelina could expand acres available for feedstock oil...
Yield10 Bioscience (NASDAQ:YTEN – Get Rating) will release its earnings data after the market closes on Wednesday, March 9th. Analysts expect Yield10 Bioscience to post earnings of ($0.64) per share for the quarter. Shares of NASDAQ YTEN traded up $0.05 during midday trading on Thursday, hitting $4.30. 34,687 shares of the company’s stock traded hands, […]
Company is Scaling up Camelina Line E3902 Seed Production and Developing Herbicide Tolerant Lines Renewable Diesel for Transportation is Driving Demand for Vegetable Oil in the U.S. and... | March 3, 2022
Dr. Oliver Peoples, the CEO of Yield10 Bioscience explains the use of Camelina seed oil as a potential source of biofuel and discusses its implications in the transportation industry in a... | February 15, 2022